21-Jan-2026
Henry Schein (HSIC) Gets a Hold from Mizuho Securities
TipRanks (Tue, 20-Jan 5:26 AM ET)
Analysts Are Bullish on These Healthcare Stocks: Henry Schein (HSIC), Boston Scientific (BSX)
TipRanks (Mon, 19-Jan 3:20 AM ET)
The 20 stocks hedge funds are most overweight
Seeking Alpha News (Sun, 18-Jan 1:01 PM ET)
Henry Schein Enters Exclusive Distribution Agreement for CytoChip's CLIA-Waived Hematology Analyzer
Business Wire (Thu, 15-Jan 10:00 AM ET)
Henry Schein Names Frederick M. Lowery as Chief Executive Officer
Business Wire (Mon, 12-Jan 7:00 AM ET)
Henry Schein to Participate in the J.P. Morgan Conference in January
Business Wire (Mon, 29-Dec 6:30 AM ET)
Henry Schein Provides Update on CEO Search Process
Business Wire (Tue, 23-Dec 4:05 PM ET)
Henry Schein Expands Partnership with vVARDIS
Business Wire (Mon, 1-Dec 4:34 PM ET)
Business Wire (Tue, 25-Nov 6:30 AM ET)
Henry Schein to Participate in Upcoming Investor Conference in December
Business Wire (Thu, 13-Nov 6:30 AM ET)
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
Henry Schein trades on the NASDAQ stock market under the symbol HSIC.
As of January 21, 2026, HSIC stock price climbed to $78.94 with 844,242 million shares trading.
HSIC has a beta of 0.26, meaning it tends to be less sensitive to market movements. HSIC has a correlation of 0.03 to the broad based SPY ETF.
HSIC has a market cap of $9.87 billion. This is considered a Mid Cap stock.
Last quarter Henry Schein reported $3 billion in Revenue and $1.38 earnings per share. This beat revenue expectation by $65 million and exceeded earnings estimates by $.11.
In the last 3 years, HSIC traded as high as $89.72 and as low as $60.01.
The top ETF exchange traded funds that HSIC belongs to (by Net Assets): VTI, VOO, VB, RSP, VBR.
HSIC has underperformed the market in the last year with a return of +7.8%, while SPY returned +15.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in HSIC shares. However, HSIC has outperformed the market in the last 3 month and 2 week periods, returning +23.5% and +0.5%, while SPY returned +2.4% and -0.9%, respectively. This indicates HSIC has been having a stronger performance recently.
HSIC support price is $76.38 and resistance is $79.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HSIC shares will trade within this expected range on the day.